UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 193

Sortiert nach

Long-Term Follow-up of the West of Scotland Coronary Prevention Study

The New England journal of medicine, 2007-10, Vol.357 (15), p.1477-1486

2007

Volltextzugriff (PDF)

Elevated Alanine Aminotransferase Predicts New-Onset Type 2 Diabetes Independently of Classical Risk Factors, Metabolic Syndrome, and C-Reactive Protein in the West of Scotland Coronary Prevention Study

Diabetes (New York, N.Y.), 2004-11, Vol.53 (11), p.2855-2860

2004

Volltextzugriff (PDF)

Association Between Apolipoprotein E4 and Cognitive Decline in Elderly Adults

Journal of the American Geriatrics Society (JAGS), 2007-11, Vol.55 (11), p.1777-1785

2007

Volltextzugriff (PDF)

C-reactive protein and prediction of coronary heart disease and global vascular events in the prospective study of pravastatin in the elderly at risk (PROSPER)

Circulation (New York, N.Y.), 2007-02, Vol.115 (8), p.981-989

2007

Volltextzugriff (PDF)

Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

The New England journal of medicine, 2009-04, Vol.360 (14), p.1395-1407

2009

Volltextzugriff (PDF)

Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the prospective study of pravastatin in the elderly at risk (PROSPER)

Circulation (New York, N.Y.), 2005-11, Vol.112 (20), p.3058-3065

2005

Volltextzugriff (PDF)

Microvolt T-Wave Alternans in End-Stage Renal Disease Patients—Associations with Uremic Cardiomyopathy

Clinical journal of the American Society of Nephrology, 2011-03, Vol.6 (3), p.519-527

2011

Volltextzugriff (PDF)

Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure

European journal of heart failure, 2009-12, Vol.11 (12), p.1152-1154

2009

Volltextzugriff (PDF)

Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study

European heart journal, 2014-02, Vol.35 (5), p.290-298

2014

Volltextzugriff (PDF)

The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

The American journal of cardiology, 1999-11, Vol.84 (10), p.1192-1197

1999

Volltextzugriff (PDF)

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

Circulation (New York, N.Y.), 2003-07, Vol.108 (4), p.414-419

2003

Volltextzugriff (PDF)

Microvolt T-Wave Alternans Testing Has No Role at Present in Guiding Therapy for Patients at High Risk of Ventricular Arrhythmias

Journal of the American College of Cardiology, 2012-02, Vol.59 (9), p.856-856

2012

Volltextzugriff (PDF)

Effect of Pravastatin on cardiovascular events in people with chronic kidney disease

Circulation (New York, N.Y.), 2004-09, Vol.110 (12), p.1557-1563

2004

Volltextzugriff (PDF)

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

The Lancet (British edition), 2002-11, Vol.360 (9346), p.1623-1630

2002

Volltextzugriff (PDF)

Prolongation of atrio-ventricular node conduction in a rabbit model of ischaemic cardiomyopathy: Role of fibrosis and connexin remodelling

Journal of molecular and cellular cardiology, 2016-05, Vol.94, p.54-64

2016

Volltextzugriff (PDF)

Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries : A randomized, double-blind, placebo-controlled study

Journal of the American College of Cardiology, 2006-09, Vol.48 (5), p.956-963

2006

Volltextzugriff (PDF)

Pravastatin and the development of diabetes mellitus : Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

Circulation (New York, N.Y.), 2001-01, Vol.103 (3), p.357-362

2001

Volltextzugriff (PDF)

Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease

Circulation (New York, N.Y.), 2005-07, Vol.112 (2), p.171-178

2005

Volltextzugriff (PDF)

Effect of activation sequence on transmural patterns of repolarization and action potential duration in rabbit ventricular myocardium

American journal of physiology. Heart and circulatory physiology, 2010-12, Vol.299 (6), p.H1812-H1822

2010

Volltextzugriff (PDF)

The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes

International journal of epidemiology, 2011-12, Vol.40 (6), p.1530-1538

2011

Volltextzugriff (PDF)

Atrial Fibrillation and Heart Failure in Cardiology Practice: Reciprocal Impact and Combined Management From the Perspective of Atrial Fibrillation: Results of the Euro Heart Survey on Atrial Fibrillation

Journal of the American College of Cardiology, 2009-05, Vol.53 (18), p.1690-1698

2009

Volltextzugriff (PDF)

Alternans of action potential duration and amplitude in rabbits with left ventricular dysfunction following myocardial infarction

Journal of molecular and cellular cardiology, 2011-03, Vol.50 (3), p.510-521

2011

Volltextzugriff (PDF)

Safety and tolerability of Pravastatin in long-term clinical trials: Prospective Pravastatin Pooling (PPP) project

Circulation (New York, N.Y.), 2002-05, Vol.105 (20), p.2341-2346

2002

Volltextzugriff (PDF)

Effect of reducing ambulance response times on deaths from out of hospital cardiac arrest: cohort study

BMJ (Online), 2001-06, Vol.322 (7299), p.1385-1388

International edition, 2001

Volltextzugriff (PDF)

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

The New England journal of medicine, 1995-11, Vol.333 (20), p.1301-1308

1995

Volltextzugriff (PDF)

1 – 25 von 193

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)
Mit Volltextzugriff
(175)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-Term Follow-up of the West of Scotland Coronary Prevention Study

Elevated Alanine Aminotransferase Predicts New-Onset Type 2 Diabetes Independently of Classical Risk Factors, Metabolic Syndrome, and C-Reactive Protein in the West of Scotland Coronary Prevention Study

Association Between Apolipoprotein E4 and Cognitive Decline in Elderly Adults

C-reactive protein and prediction of coronary heart disease and global vascular events in the prospective study of pravastatin in the elderly at risk (PROSPER)

Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the prospective study of pravastatin in the elderly at risk (PROSPER)

Microvolt T-Wave Alternans in End-Stage Renal Disease Patients—Associations with Uremic Cardiomyopathy

Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure

Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study

The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

Microvolt T-Wave Alternans Testing Has No Role at Present in Guiding Therapy for Patients at High Risk of Ventricular Arrhythmias

Effect of Pravastatin on cardiovascular events in people with chronic kidney disease

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Prolongation of atrio-ventricular node conduction in a rabbit model of ischaemic cardiomyopathy: Role of fibrosis and connexin remodelling

Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries : A randomized, double-blind, placebo-controlled study

Pravastatin and the development of diabetes mellitus : Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease

Effect of activation sequence on transmural patterns of repolarization and action potential duration in rabbit ventricular myocardium

The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes

Atrial Fibrillation and Heart Failure in Cardiology Practice: Reciprocal Impact and Combined Management From the Perspective of Atrial Fibrillation: Results of the Euro Heart Survey on Atrial Fibrillation

Alternans of action potential duration and amplitude in rabbits with left ventricular dysfunction following myocardial infarction

Safety and tolerability of Pravastatin in long-term clinical trials: Prospective Pravastatin Pooling (PPP) project

Effect of reducing ambulance response times on deaths from out of hospital cardiac arrest: cohort study

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

Suchergebnisse filtern